The EU-funded project REBECCA taps into the potential of Real-World Data to support clinical research and to improve existing clinical workflows.
It will combine clinical data with data obtained from multiple wearable, online behaviour and registry data to study the complex array of chronic comorbidities developed during breast cancer recovery. The data will be deployed within 7 clinical studies in 3 countries, involving over 650 individuals, and it will help shape future guidelines and practices for post-cancer treatment.
How will you benefit from REBECCA?
Sign up to our newsletter
Sign up for our mailing list to receive occasional emails as we publish key project materials and commission new strands of work.
More impact of clinical research on breast cancer patients
Clinical and technological universities, industry leaders, public health experts, and patient associations will work together to shape guidelines and practices for post-cancer treatment. Best practices from the REBECCA studies will be disseminated to researchers, public health and regulatory bodies throughout Europe to facilitate wider adoption of RWD in clinical research.
REBECCA will provide an infrastructure for continued progress on the use of RWD beyond the project, facilitating the mass adoption of RWD as a valuable clinical research and patient management tool.
Find Out More
How we will do it
Our work packages are evolving, but include consideration and development of:
Find out about the latest REBECCA related news.
INCLIVA and the Clinical Hospital of València held the second Meeting with breast cancer patient associations to showcase the latest advances in research
Researchers emphasise the importance of adopting healthy lifestyle habits regarding nutrition and physical exercise. València, February 6, 2024. The INCLIVA Health Research Institute, together with the Breast Cancer Unit of the University Clinical Hospital of València, organised a meeting w…
Uniting Innovation and Collaboration: The Cancer Survivorship – AI for Well-being Cluster
In the ever-evolving world of eHealth, a dynamic cluster has emerged with a mission to foster collaboration and drive innovation: The “Cancer Survivorship – AI for Well-being” . Imagine a collective force of organisations united by a common purpose – to tackle crucial concerns such as well-being,…
Personalised Post-Cancer Consultations: Unified Guidelines & Standards by Karolinska Institutet
At the core of the REBECCA project lies the mission to provide personalised advice, using real-world data to improve patients’ follow-up and their quality-of-life, after their primary treatment. Towards this goal, the project, during the planned intervention studies, will support personalised lif…
The project brings together 12 partners from 7 European countries. Clinical and technological universities, industry leaders, public health experts, and patient associations will work together to shape guidelines and practices for post-cancer treatment.
“Cancer Survivorship – AI for Well-being”
Rebecca is a member of the “Cancer Survivorship – AI for Well-being” (CS_AIW) consortium, a collection of EU-funded projects that were launched in late 2020 under the banner of “Breaking Down Silos”. These projects share two fundamental principles. Firstly, they all aim to tackle critical issues surrounding mental health, well-being, depression, and patient support. Secondly, they embrace a participatory research philosophy, promoting a cohesive and collaborative approach to their endeavours.
Find Out More